Literature DB >> 14755057

STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells.

Nikolai N Khodarev1, Michael Beckett, Edwardine Labay, Thomas Darga, Bernard Roizman, Ralph R Weichselbaum.   

Abstract

Nu61, a radiation-resistant human tumor xenograft, was selected from a parental radiosensitive tumor SCC-61 by eight serial cycles of passage in athymic nude mice and in vivo irradiation. Replicate DNA array experiments identified 52 genes differentially expressed in nu61 tumors compared with SCC-61 tumors. Of these, 19 genes were in the IFN-signaling pathway and moreover, 25 of the 52 genes were inducible by IFN in the nu61 cell line. Among the genes involved in IFN signaling, STAT1alpha and STAT1beta were the most highly overexpressed in nu61 compared to SCC-61. STAT1alpha and STAT1beta cDNAs were cloned and stably transfected into SCC-61 tumor cells. Clones of SCC-61 tumor cells transfected with vectors expressing STAT1alpha and STAT1beta demonstrated radioprotection after exposure to 3 Gy (P < 0.038). The results indicate that radioresistance acquired during radiotherapy treatment may account for some treatment failures and demonstrate an association of acquired tumor radioresistance with up-regulation of components of the IFN-related signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755057      PMCID: PMC341831          DOI: 10.1073/pnas.0308102100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  IRF family of transcription factors as regulators of host defense.

Authors:  T Taniguchi; K Ogasawara; A Takaoka; N Tanaka
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 2.  The evolution of diverse biological responses to DNA damage: insights from yeast and p53.

Authors:  G M Wahl; A M Carr
Journal:  Nat Cell Biol       Date:  2001-12       Impact factor: 28.824

3.  Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2.

Authors:  Mansoor M Ahmed; Rachael A Alcock; Damodaran Chendil; Swatee Dey; Anindita Das; Kolaparthi Venkatasubbarao; Mohammed Mohiuddin; LuZhe Sun; William E Strodel; James W Freeman
Journal:  J Biol Chem       Date:  2001-11-01       Impact factor: 5.157

4.  Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase.

Authors:  B Thyagarajan; E C Olivares; R P Hollis; D S Ginsburg; M P Calos
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

5.  p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors.

Authors:  D A Haas-Kogan; S S Kogan; G Yount; J Hsu; M Haas; D F Deen; M A Israel
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-15       Impact factor: 7.038

Review 6.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

7.  Influence of interferon-gamma on radiation-induced apoptosis in normal and ataxia-telangiectasia fibroblast cell lines.

Authors:  M Savoldi-Barbosa; E T Sakamoto-Hojo
Journal:  Teratog Carcinog Mutagen       Date:  2001

8.  Dose-dependent and independent temporal patterns of gene responses to ionizing radiation in normal and tumor cells and tumor xenografts.

Authors:  N N Khodarev; J O Park; J Yu; N Gupta; E Nodzenski; B Roizman; R R Weichselbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

Review 9.  HSV gene functions: what have we learned that could be generally applicable to its near and distant cousins?

Authors:  B Roizman
Journal:  Acta Virol       Date:  1999 Apr-Jun       Impact factor: 1.162

Review 10.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

View more
  133 in total

1.  Human Papillomavirus 16 E2 Regulates Keratinocyte Gene Expression Relevant to Cancer and the Viral Life Cycle.

Authors:  Michael R Evans; Claire D James; Molly L Bristol; Tara J Nulton; Xu Wang; Namsimar Kaur; Elizabeth A White; Brad Windle; Iain M Morgan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  STAT3 Inhibition Induces Apoptosis in Cancer Cells Independent of STAT1 or STAT2.

Authors:  Adetola Shodeinde; Kalyani Ginjupalli; H Dan Lewis; Sheraz Riaz; Beverly E Barton
Journal:  J Mol Biochem       Date:  2013-02-20

3.  ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression.

Authors:  Sun-Hee Kim; Yun-Yong Park; Sang-Wook Kim; Ju-Seog Lee; Dingzhi Wang; Raymond N DuBois
Journal:  Cancer Res       Date:  2011-09-21       Impact factor: 12.701

4.  Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden.

Authors:  Peter J Klover; William J Muller; Gertraud W Robinson; Ruth M Pfeiffer; Daisuke Yamaji; Lothar Hennighausen
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

5.  Developing Predictive or Prognostic Biomarkers for Charged Particle Radiotherapy.

Authors:  Michael D Story; Jing Wang
Journal:  Int J Part Ther       Date:  2018

6.  Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell death.

Authors:  Anna A Kondratova; HyeonJoo Cheon; Beihua Dong; Elise G Holvey-Bates; Metis Hasipek; Irina Taran; Christina Gaughan; Babal K Jha; Robert H Silverman; George R Stark
Journal:  EMBO J       Date:  2020-04-23       Impact factor: 11.598

7.  Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer.

Authors:  Merit L Goodman; Gloria M Trinca; Katherine R Walter; Evangelia K Papachristou; Clive S D'Santos; Tianbao Li; Qi Liu; Zhao Lai; Prabhakar Chalise; Rashna Madan; Fang Fan; Mary A Markiewicz; Victor X Jin; Jason S Carroll; Christy R Hagan
Journal:  J Immunol       Date:  2019-04-01       Impact factor: 5.422

8.  Identification of a natural compound by cell-based screening that enhances interferon regulatory factor-1 activity and causes tumor suppression.

Authors:  Jinbo Gao; Yujun Wang; Quanhua Xing; Jin Yan; Maheswari Senthil; Yasir Akmal; Claudia M Kowolik; Julia Kang; David M Lu; Ming Zhao; Zhixiu Lin; Christopher H K Cheng; M L Richard Yip; John H Yim
Journal:  Mol Cancer Ther       Date:  2011-08-04       Impact factor: 6.261

Review 9.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

10.  RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation.

Authors:  Ryan C Widau; Akash D Parekh; Mark C Ranck; Daniel W Golden; Kiran A Kumar; Ravi F Sood; Sean P Pitroda; Zhengkai Liao; Xiaona Huang; Thomas E Darga; David Xu; Lei Huang; Jorge Andrade; Bernard Roizman; Ralph R Weichselbaum; Nikolai N Khodarev
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.